Pulled from Benzinga Pro data, Mesa Laboratories (NASDAQ:MLAB) posted Q3 earnings of $451 thousand, an increase from Q2 of 65.47%. Sales dropped to $54.29 million, a 7.6% decrease between quarters. In Q2, Mesa Laboratories earned $1.31 million, and total sales reached $58.75 million.
Why Is ROIC Significant?
Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company's ROIC. A higher ROIC is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROIC suggests the opposite. In Q3, Mesa Laboratories posted an ROIC of 0.7%.
Keep in mind, while ROIC is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.
For Mesa Laboratories, the positive return on invested capital ratio of 0.7% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
Analyst Predictions
Mesa Laboratories reported Q3 earnings per share at $2.35/share, which beat analyst predictions of $0.14/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
